31

Mar

2021

17:00

BST

Webinar

Improving Efficiency in Stroke Prevention

Average (ratings)
No ratings
Your rating

Overview

LAA closure (LAAC) is a proven alternative to oral anticoagulation for preventing stroke in patients with non-valvular AF.

Please join this webinar at 6pm CEST / 5pm BST on LAAC Patient Management in the COVID-19 Era to reinforce the importance to treat LAA closure patients, overcome barriers during a pandemic and optimizing an elective procedure with the new LAA closure device WATCHMAN FLX.

 

 

 

Faculty:


David Hildick-Smith

David Hildick-Smith


Tim Betts

Tim Betts


A John Camm

A John Camm

This webinar is supported by

Agenda

Rationale for an alternative to DOAC in stroke prevention – J. Camm

- Limitations of lifelong DOAC therapy
- High bleeding risk and special subgroups
- PRAGUE-17, OPTION, CHAMPION-AF

Case presentation – FLX with early discharge – D. Hildick-Smith

- Clinical history
- CT scan – anatomic considerations

Current state of LAAC with a new generation device – T. Betts

- From EWOLUTION to NCDR and PINNACLE FLX

Case conclusion – D. Hildick-Smith

- Implantation technique
- Imaging guidance selection / anesthesia (GA vs. sedation)
- Post-procedure antithrombotic therapy

Panel Discussion and Conclusion

Learning Objectives

  • Discuss the emerging evidence for the LAA closure therapy in the era of NOACs.
  • Share experience about the management of elective procedures during the pandemic to offer treatment for patients at high risk for stroke.
  • Learn how new imaging modalities (ICE, mini-micro TEE, CT) and workstreams could reduce the need for General Anesthesia, streamlining the LAAC procedure and the patient follow-up.
  • Learn about the latest LAAC clinical data and the proven safety profile of WATCHMAN FLX.
  • Understand how the new implantation technique of WATCHMAN FLX can optimize procedural results.

Audience

  • Interventional Cardiologists
  • Electrophysiologists

Faculty Biographies


David Hildick-Smith

David Hildick-Smith

Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit.

View full profile

Tim Betts

Tim Betts

John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, UK

View full profile

A John Camm

A John Camm

John Camm is British Heart Foundation Professor of Clinical Cardiology (Emeritus) at St George’s University of London, London, UK. His interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, and anticoagulation.

View full profile